DDX5
Probable ATP-dependent RNA helicase DDX5
Also known as: DDX5_HUMAN, G17P1, HLR1, p68
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17844
- Gene
- DDX5
- Ensembl
- ENSG00000108654
- Chromosome
- 17
- Canonical length
- 614 aa
- Protein class
- Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a member of the DEAD box family of RNA helicases that are involved in a variety of cellular processes as a result of its role as an adaptor molecule, promoting interactions with a large number of other factors. This protein is involved in pathways that include the alteration of RNA structures, plays a role as a coregulator of transcription, a regulator of splicing, and in the processing of small noncoding RNAs. Members of this family contain nine conserved motifs, including the conserved Asp-Glu-Ala-Asp (DEAD) motif, important to ATP binding and hydrolysis as well as RNA binding and unwinding activities. Dysregulation of this gene may play a role in cancer development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2017]
Canonical amino-acid sequenceUniProt
614 residues, UniProt reviewed canonical sequence.
>P17844|DDX5
1 MSGYSSDRDR GRDRGFGAPR FGGSRAGPLS GKKFGNPGEK LVKKKWNLDE LPKFEKNFYQ
61 EHPDLARRTA QEVETYRRSK EITVRGHNCP KPVLNFYEAN FPANVMDVIA RQNFTEPTAI
121 QAQGWPVALS GLDMVGVAQT GSGKTLSYLL PAIVHINHQP FLERGDGPIC LVLAPTRELA
181 QQVQQVAAEY CRACRLKSTC IYGGAPKGPQ IRDLERGVEI CIATPGRLID FLECGKTNLR
241 RTTYLVLDEA DRMLDMGFEP QIRKIVDQIR PDRQTLMWSA TWPKEVRQLA EDFLKDYIHI
301 NIGALELSAN HNILQIVDVC HDVEKDEKLI RLMEEIMSEK ENKTIVFVET KRRCDELTRK
361 MRRDGWPAMG IHGDKSQQER DWVLNEFKHG KAPILIATDV ASRGLDVEDV KFVINYDYPN
421 SSEDYIHRIG RTARSTKTGT AYTFFTPNNI KQVSDLISVL REANQAINPK LLQLVEDRGS
481 GRSRGRGGMK DDRRDRYSAG KRGGFNTFRD RENYDRGYSS LLKRDFGAKT QNGVYSAANY
541 TNGSFGSNFV SAGIQTSFRT GNPTGTYQNG YDSTQQYGSN VPNMHNGMNQ QAYAYPATAA
601 APMIGYPMPT GYSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DDX5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 256 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 256 nTPM
- thymus: 254 nTPM
- urinary bladder: 213 nTPM
- bone marrow: 207 nTPM
- retina: 196 nTPM
- cervix: 179 nTPM
Single-cell type
- pituicytes/fscs: 1,391 nCPM
- endometrial secretory cells: 1,385 nCPM
- epididymal basal cells: 1,308 nCPM
- ocular epithelial cells: 1,232 nCPM
- endometrial luminal cells: 1,202 nCPM
- breast lactating cells: 1,129 nCPM
Immune cell
- total PBMC: 320 nTPM
- basophil: 233 nTPM
- non-classical monocyte: 198 nTPM
- eosinophil: 171 nTPM
- classical monocyte: 161 nTPM
- MAIT T-cell: 150 nTPM
Brain region
- choroid plexus: 269 nTPM
- white matter: 215 nTPM
- cerebellum: 205 nTPM
- cerebral cortex: 196 nTPM
- thalamus: 193 nTPM
- medulla oblongata: 192 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.1
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.76
- DepMap mean gene effect
- -0.78
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alternative mRNA splicing, via spliceosome
- androgen receptor signaling pathway
- BMP signaling pathway
- epithelial to mesenchymal transition
- estrogen receptor signaling pathway
- intrinsic apoptotic signaling pathway by p53 class mediator
- mRNA splicing, via spliceosome
- mRNA transcription
- myoblast differentiation
- negative regulation of transcription by RNA polymerase II
- nuclear-transcribed mRNA catabolic process
- positive regulation of DNA damage response, signal transduction by p53 class mediator
- primary miRNA processing
- regulation of alternative mRNA splicing, via spliceosome
- regulation of androgen receptor signaling pathway
- regulation of osteoblast differentiation
- regulation of skeletal muscle cell differentiation
- regulation of transcription by RNA polymerase II
- regulation of viral genome replication
- rhythmic process
- miRNA transcription
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium-dependent protein binding
- calmodulin binding
- enzyme binding
- MH2 domain binding
- mRNA 3'-UTR binding
- mRNA binding
- nuclear androgen receptor binding
- pre-mRNA binding
- primary miRNA binding
- promoter-specific chromatin binding
- R-SMAD binding
- ribonucleoprotein complex binding
- RNA binding
- RNA helicase activity
- SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP-dependent RNA helicase DEAD-box, conserved site
- Helicase, C-terminal domain-like
- DEAD/DEAH-box helicase domain
- Helicase superfamily 1/2, ATP-binding domain
- RNA helicase, DEAD-box type, Q motif
- P-loop containing nucleoside triphosphate hydrolase
- DEAD/DEAH box helicase
- Helicase conserved C-terminal domain
- RNA helicase p68 repeat
- P68HR (NUC004) repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DDX5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DDX5 as an antibody target. Whether an autoantibody or antibody against DDX5 could matter depends on whether native DDX5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DDX5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DDX5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...